Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Yumin ^a   Yang, Cuihong ^a   Wang, Weiwei ^b   Liu, Jinjian ^a   Liu, Qiang ^a   Huang, Fan ^a   Chu, Liping ^a   Gao, Honglin ^a   Li, Chen ^b   Kong, Deling ^b   Liu, Qian ^c   Liu, Jianfeng ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^c TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; DOXORUBICIN; NANOPARTICLE; PRODRUG;

CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; NEOPLASMS; PH; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CURCUMIN; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; NEOPLASMS; PRODRUGS;

EID: 84958260735     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21225     Document Type: Article

References (48)

1. Huang, P. et al. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J. Am. Chem. Soc. 136, 11748-11756, (2014).
2. Zou, P. et al. Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse. Int. J. Clin. Exp. Pathol. 7, 4607-4616 (2014).
3. Duan, X. et al. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS nano 7, 5858-5869, (2013).
4. Podder, H. et al. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J. Am. Soc. Neohrol. 12, 1059-1071 (2001).
5. Mayer, L. D. et al. Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice. Mol. Cancer. Ther. 5, 1854-1863, (2006).
6. Wang, W. et al. A reconstituted "two into one" thermosensitive hydrogel system assembled by drug-loaded amphiphilic copolymernanoparticles for the local delivery of paclitaxel. J. Mater. Chem. B. 1, 552-563, (2013).
7. Wang, W. et al. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(epsilon-caprolactone) and poly(ethylene glycol)co-polymer. Acta biomater 8, 3963-3973, (2012).
8. Li, J. et al. Self-delivery multifunctional anti-HIV hydrogels for sustained release. Adv. Healthc. Mater. 2, 1586-1590, (2013).
9. Kuang, Y. et al. Pericellular hydrogel/nanonets inhibit cancer cells. Angew. Chem. Int. Ed. Engl. 53, 8104-8107, (2014).
10. Wang, H. Y. C., Wang, L., Kong, D., Zhang, Y., Yang, Z. Self-assembled nanospheres as a novel delivery system for taxol: a molecular hydrogel with nanosphere morphology. Chem. Commun. 47, 4439-4441 (2011).
11. Ding, D. et al. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system. ACS nano 5, 2520-2534, (2011).
12. Win, K. Y., Teng, C. P., Ye, E., Low, M., Han, M. Y. Evaluation of polymeric nanoparticle formulations by effective imaging and quantitation of cellular uptake for controlled delivery of doxorubicin. Small 11, 1197-1204, (2015).
13. Seo, B. B., Choi, H., Koh, J. T., Song, S. C. Sustained BMP-2 delivery and injectable bone regeneration using thermosensitive polymeric nanoparticle hydrogel bearing dual interactions with BMP-2. J. Control. Release. 209, 67-76, (2015).
14. Li, Y., Wu, J., Xie, Y., Ju, H. An efficient polymeric micromotor doped with Pt nanoparticle@carbon nanotubes for complex biomedia. Chem. Commun. 51, 6325-6328, (2015).
15. Ding, D. et al. Conjugated polyelectrolyte-cisplatin complex nanoparticles for simultaneous in vivo imaging and drug tracking. Nanoscale 3, 1997-2002, (2011).
16. Pasut, G. et al. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. J. Control. Release. 199, 106-113, (2015).
17. Cheng, W., Compton, R. G. Investigation of single-drug-encapsulating liposomes using the nano-impact method. Angew. Chem. Int. Ed. Engl. 53, 13928-13930, (2014).
18. Bao, Q. Y. et al. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles. Int. J. Pharm. 477, 408-415, (2014).
19. Liu, J. et al. Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery. Int. J. Nanomedicine. 9, 197-207, (2014).
20. Liu, J. et al. Self-assembling peptide of D-amino acids boosts selectivity and antitumor efficacy of 10-hydroxycamptothecin. ACS. Appl. Mater. Interfaces. 6, 5558-5565, (2014).
21. Li, Y. et al. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. Biomaterials 41, 1-14, (2015).
22. Li, K. et al. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy. Biomaterials 39, 131-144, (2015).
23. Mieszawska, A. J. et al. Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy. Bioconjug. Chem. 24, 1429-1434, (2013).
24. Ma, L., Kohli, M., Smith, A. Nanoparticles for combination drug therapy. ACS nano 7, 9518-9525, (2013).
25. Yu, D. et al. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo. J. Control. Release. 110, 90-102, (2005).
26. Kratz, F., Muller, I. A., Ryppa, C., Warnecke, A. Prodrug strategies in anticancer chemotherapy. Chem.Med.Chem. 3, 20-53, (2008).
27. Khandare, J. J., Chandna, P., Wang, Y., Pozharov, V. P., Minko, T. Novel polymeric prodrug with multivalent components for cancer therapy. J. Pharmacol. Exp. Ther. 317, 929-937, (2006).
28. Delplace, V., Couvreur, P., Nicolas, J. Recent trends in the design of anticancer polymer prodrug nanocarriers. Polym. Chem. 5, 1529-1544, (2014).
29. She, W. et al. Dendronized heparin doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials 34, 2252-2264, (2013).
30. Lee, M., Jeong, J., Kim, D. Intracellular uptake and pH-dependent release of doxorubicin from the self-assembled micelles based on amphiphilic polyaspartamide graft copolymers. Biomacromolecules 16, 136-144, (2015).
31. Liu, J. et al. Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo. Nanoscale 7, 4451-4460 (2015).
32. Bae, Y., Fukushima, S., Harada, A., Kataoka, K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. Engl. 42, 4640-4643, (2003).
33. Xu, W. et al. Doxorubicin encapsulated in micelles enhances radiosensitivity in doxorubicin-resistant tumor cells. Discov. Med. 18, 169-177 (2014).
34. Song, Z., Zhu, W., Liu, N., Yang, F., Feng, R. Linolenic acid-modified PEG-PCL micelles for curcumin delivery. Int. J. Pharm. 471, 312-321, (2014).
35. Yu, Y. et al. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery. Biomacromolecules 15, 524-532, (2014).
36. Ghorai, A., Mondal, J., Chandra, R., Patra, G. K. A reversible fluorescent-colorimetric imino-pyridyl bis-Schiff base sensor for expeditious detection of Al and HSO in aqueous media. Dalton Trans. 44, 13261-13271, (2015).
37. Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol.Rev. 56, 185-229, (2004).
38. Gewirtz, D. A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem.Iochem. Pharmacol. 57, 727-741 (1999).
39. Ketron, A. C., Gordon, O. N., Schneider, C., Osheroff, N. Oxidative metabolites of curcumin poison human type II topoisomerases. Biochemistry 52, 221-227, (2013).
40. Prabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., Gong, S. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Biomaterials 30, 5757-5766, (2009).
41. Ryu, J. H., Bickerton, S., Zhuang, J., Thayumanavan, S. Ligand-decorated nanogels: fast one-pot synthesis and cellular targeting. Biomacromolecules 13, 1515-1522, (2012).
42. Zhang, C., Wu, Y., Dong, Y., Xu, H., Zhao, L. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.Pharm.Biol. 1-7, (2015).
43. Ren, S. et al. Comparison of pharmacokinetics, tissue distribution and pharmacodynamics of liposomal and free doxorubicin in tumour-bearing mice following intratumoral injection. J. Pharm Pharmacol. 66. 1231-1239(2014).
44. Cao, N., Feng, S. S. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 29, 3856-3865, (2008).
45. Lv, S. et al. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Biomaterials 35, 6118-6129, (2014).
46. Chen, W., Meng, F., Cheng, R., Zhong, Z. pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: A comparative study with micelles. J. Control. Release. 142, 40-46, (2010).
47. Ramalingam, P., Ko, Y. T. A validated LC-MS/MS method for quantitative analysis of curcumin in mouse plasma and brain tissue and its application in pharmacokinetic and brain distribution studies. J Chromatogr B. 969, 101-108, (2014).
48. Wei, T. et al. Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo. Nano. Lett. 13, 2528-2534, (2013).